Meyka AI API is live for developers.Start building.
Advertisement
Standard BioTools Inc.

Standard BioTools Inc. (FLDM) Stock Overview

Explore Standard BioTools Inc.’s financial performance, market position, analyst ratings, and future outlook.

FLDM●NASDAQ
HealthcareMedical - Diagnostics & Research
$3.71
$0.28(7.02%)
U.S. Market opens in 51h 49m
Advertisement

Standard BioTools Inc. (FLDM)

Meyka AI Score

Z

Key Financials

Market Cap294.2M
P/E Ratio18.42
EPS (TTM)$-0.78
ROE0.17%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

FLDM Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Standard BioTools Inc. (FLDM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 18.42 and a market capitalization of 294.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
5.70%
3-Year Change
6.92%
5-Year Change
-45.76%
All-Time (Max) Change
-73.54%

Contact Information

https://www.fluidigm.com
16502666000
7000 Shoreline Ct Ste 100, South San Francisco, CA, 94080

Company Facts

6,150 Employees
IPO DateFeb 10, 2011
CountryUS

Frequently Asked Questions